WallStreetZenWallStreetZen
Analyst Ranking
Top 1%
#21 out of 3732 analysts
Average Return
+34.48%
Win Rate
53%44 out of 83
Risk vs Reward
Poor
Good

Alethia Young's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
PACIFIC BIOSCIENCES OF CALIFORNIA INCPACB
+781.46%$3.56$31.38
2020-03-09 -
2021-03-09
Strong Buy
CURIS INCCRIS
+479.03%$1.24$7.18
2020-07-17 -
2021-07-16
Strong Buy
ANAPTYSBIO INCANAB
+260.34%$23.85$85.94
2017-08-25 -
2018-08-24
Buy
SAREPTA THERAPEUTICS INCSRPT
+214.48%$45.38$142.71
2017-09-07 -
2018-09-07
Buy
RA PHARMACEUTICALS INCRARX
+206.85%$10.07$30.90
2018-08-07 -
2019-08-07
Buy

Alethia Young's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
ARENA PHARMACEUTICALS INCARNA
5Hold$100.00+0.01%Downgrades
5 months ago
THESEUS PHARMACEUTICALS INCTHRX
1Strong Buy$25.00+249.16%Initiates Coverage On
7 months ago
BIOGEN INCBIIB
4Hold$327.00+63.79%Maintains
7 months ago
ADVERUM BIOTECHNOLOGIES INCADVM
2Hold$3.00+250.88%Downgrades
10 months ago
RAPT THERAPEUTICS INCRAPT
1Strong Buy$71.00+428.27%Maintains
a year ago
VERTEX PHARMACEUTICALS INCVRTX
3Strong Buy$281.00+8.67%Maintains
a year ago
PROVENTION BIO INCPRVB
2Strong Buy$25.00N/AMaintains
a year ago
LONGBOARD PHARMACEUTICALS INCLBPH
1Strong Buy$32.00N/AInitiates Coverage On
a year ago
ELEDON PHARMACEUTICALS INCELDN
1Strong Buy$25.00N/AInitiates Coverage On
a year ago
NEXIMMUNE INCNEXI
1Strong Buy$35.00N/AInitiates Coverage On
a year ago
AKEBIA THERAPEUTICS INCAKBA
1Strong Buy$8.00N/AInitiates Coverage On
a year ago
FATE THERAPEUTICS INCFATE
1Strong Buy$98.00N/AMaintains
a year ago
REGENERON PHARMACEUTICALS INCREGN
2Strong Buy$656.00N/AMaintains
a year ago
AMGEN INCAMGN
6Strong Buy$295.00N/AMaintains
a year ago
BICYCLE THERAPEUTICS PLCBCYC
1Strong Buy$30.00N/AInitiates Coverage On
2 years ago
GILEAD SCIENCES INCGILD
2Strong Buy$84.00N/AMaintains
2 years ago
ALX ONCOLOGY HOLDINGS INCALXO
1Strong Buy$64.00N/AInitiates Coverage On
2 years ago
CURIS INCCRIS
1Strong Buy$4.00N/AInitiates Coverage On
2 years ago
INTERCEPT PHARMACEUTICALS INCICPT
1HoldN/AN/ADowngrades
2 years ago
TG THERAPEUTICS INCTGTX
1Strong Buy$35.00N/AMaintains
2 years ago
MARINUS PHARMACEUTICALS INCMRNS
1Strong Buy$6.00N/AReiterates
2 years ago
STEMLINE THERAPEUTICS INCSTML
2Hold$12.50N/ADowngrades
2 years ago
ASCENDIS PHARMA AASND
5Strong Buy$201.00N/AReiterates
2 years ago
ARROWHEAD PHARMACEUTICALS INCARWR
2Strong Buy$60.00N/AUpgrades
2 years ago
PTC THERAPEUTICS INCPTCT
3Strong Buy$85.00N/AReiterates
2 years ago
ARCUS BIOSCIENCES INCRCUS
1Strong Buy$21.00N/AInitiates Coverage On
2 years ago
PACIFIC BIOSCIENCES OF CALIFORNIA INCPACB
1Strong Buy$5.00N/AAssumes
2 years ago
AURINIA PHARMACEUTICALS INCAUPH
1Strong Buy$32.00N/AMaintains
2 years ago
VERASTEM INCVSTM
1Strong Buy$6.00N/AMaintains
2 years ago
SAREPTA THERAPEUTICS INCSRPT
6Strong Buy$217.00N/AReiterates
2 years ago
AGIOS PHARMACEUTICALS INCAGIO
4Strong Buy$70.00N/AReiterates
2 years ago
INCYTE CORPINCY
2Hold$65.00N/AMaintains
2 years ago
SPECTRUM PHARMACEUTICALS INCSPPI
1Hold$4.00N/ADowngrades
2 years ago
RA PHARMACEUTICALS INCRARX
3Buy$17.00N/AMaintains
4 years ago
ANAPTYSBIO INCANAB
2Buy$104.00N/AInitiates Coverage On
4 years ago
ALEXION PHARMACEUTICALS INCALXN
3Buy$154.00N/AMaintains
4 years ago
TESARO INCTSRO
3Buy$128.00N/AMaintains
4 years ago
MESOBLAST LTDMESO
1SellN/AN/ADowngrades
4 years ago
ALNYLAM PHARMACEUTICALS INCALNY
3Buy$154.00N/AMaintains
4 years ago
BIOMARIN PHARMACEUTICAL INCBMRN
2Buy$116.00N/AMaintains
4 years ago
CELGENE CORPCELG
1Buy$129.00N/AMaintains
4 years ago
AMERISOURCEBERGEN CORPABC
1Buy$112.00N/AMaintains
4 years ago
PUMA BIOTECHNOLOGY INCPBYI
4Buy$106.00N/AMaintains
4 years ago
BIOVERATIV INCBIVV
3Hold$105.00N/AMaintains
4 years ago
ACCELERON PHARMA INCXLRN
1Buy$51.00N/AMaintains
5 years ago
INTELLIA THERAPEUTICS INCNTLA
1Buy$28.00N/AMaintains
5 years ago
DARDEN RESTAURANTS INCDRI
1Hold$82.00N/AMaintains
5 years ago
UNITED THERAPEUTICS CORPUTHR
1SellN/AN/AInitiates Coverage On
5 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.